Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Mazumdar Claire. Insider active across 1 company, notably Bicara Therapeutics Inc.. Aggregated, 17 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €791k. History available since 13 October 2025. The latest transaction was disclosed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Mazumdar Claire
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
10,000 shares@ US$3.7898Common StockSEC:0001470831-26-000813:0
10,000 shares@ US$27.975Common StockSEC:0001470831-26-000813:1
10,000 shares@ US$3.78980.0020% mcap2.2% of flowCommon StockSEC:0001470831-26-000714:0
9,972 shares@ US$28.41630.015% mcap16.3% of flowCommon StockSEC:0001470831-26-000714:1
28 shares@ US$29.680.0000% mcap0.0% of flowCommon StockSEC:0001470831-26-000714:2
8,226 shares@ US$4.43690.0018% mcap7.1% of flowCommon StockSEC:0001628280-26-026089:0
7,454 shares@ US$3.78980.0014% mcap5.5% of flowCommon StockSEC:0001628280-26-026089:1
7,080 shares@ US$5.45370.0019% mcap7.5% of flowCommon StockSEC:0001628280-26-026089:2
15,000 shares@ US$3.78980.0029% mcap11.1% of flowCommon StockSEC:0001628280-26-026089:3
15,000 shares@ US$23.60970.018% mcap68.9% of flowCommon StockSEC:0001628280-26-026089:4
6,499 shares@ US$3.78984.7% of flowCommon StockSEC:0001628280-26-020236:0
36,766 shares@ US$3.789812.4% of flowCommon StockSEC:0001628280-26-016874:0
2,631 shares@ US$3.78980.9% of flowCommon StockSEC:0001628280-26-015778:0
29,500 shares@ US$5.453716.2% of flowCommon StockSEC:0002034671-25-000012:0
41,163 shares@ US$3.789819.1% of flowCommon StockSEC:0002034671-25-000009:0
24,103 shares@ US$3.789813.6% of flowCommon StockSEC:0002034671-25-000006:0
11,445 shares@ US$3.78986.5% of flowCommon StockSEC:0002034671-25-000003:0
About Mazumdar Claire
Mazumdar Claire is Chief Executive Officer at Bicara Therapeutics Inc. (XNAS). She has made 15 filings in total. Across the sampled recent filings from 2025-10-15 to 2026-07-14, buy volume is EUR 0 and sell volume is EUR 548768, with Levée d'options as the modal transaction nature.